Magnetite mesoporous silica nanoparticles embedded in carboxybetaine methacrylate for application in hyperthermia and drug delivery

被引:22
作者
Keshavarz, Hasan [1 ]
Khavandi, Alireza [1 ]
Alamolhoda, Somaye [1 ]
Naimi-Jamal, M. Reza [2 ]
机构
[1] Iran Univ Sci & Technol, Sch Met & Mat Engn, POB 13114-16846, Tehran, Iran
[2] Iran Univ Sci & Technol, Dept Chem, Res Lab Green Organ Synth & Polymers, POB 13114-16846, Tehran, Iran
关键词
IRON-OXIDE NANOPARTICLES; SURFACE MODIFICATION; ADSORPTION; RESISTANCE; THERAPY; RELEASE;
D O I
10.1039/d0nj00939c
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Magnetite mesoporous silica nanoparticles (MMSNs) are biocompatible and can easily deliver a drug to the target tissue, but there are two challenges: burst effect and protein corona. In this study, poly(carboxybetaine methacrylate) (pCBMA) coating was used for MMSNs because pCBMA inhibits protein uptake. Tamoxifen is loaded onto magnetite mesoporous silica nanoparticles and then embedded in pCBMA nanogels. The drug release was studied for 125 h at temperatures of 37 and 43 degrees C and pH values of 6.7 and 7.4. Our results show that less than 20% of the drug is released within 24 hours for all samples. MTT assay was performed to determine the biocompatibility of the nanogels. The results show that nanogels are biocompatible at high concentrations. The growth and proliferation of L929 cells after 72 hours were studied. In this study, hyperthermia (in vitro) was investigated and the nanogels showed good heat production capability.
引用
收藏
页码:8232 / 8240
页数:9
相关论文
共 50 条
  • [41] Recent advances in mesoporous silica nanoparticles formulations and drug delivery for wound healing
    Heidari, Razieh
    Assadollahi, Vahideh
    Manesh, Mohammad Hossein Shakib
    Mirzaei, Seyed Abbas
    Elahian, Fatemeh
    [J]. INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2024, 665
  • [42] Glutathione-sensitive hollow mesoporous silica nanoparticles for controlled drug delivery
    Moghaddam, Seyyed Pouya Hadipour
    Yazdimamaghani, Mostafa
    Ghandehari, Hamidreza
    [J]. JOURNAL OF CONTROLLED RELEASE, 2018, 282 : 62 - 75
  • [43] Insight on the Dependence of the Drug Delivery Applications of Mesoporous Silica Nanoparticles on Their Physical Properties
    Fathy, Mohamed M.
    Yassin, Fatma M.
    Elshemey, Wael M.
    Fahmy, Heba M.
    [J]. SILICON, 2023, 15 (01) : 61 - 70
  • [44] Glutathione and pH serial responsive functional mesoporous silica nanoparticles for drug delivery
    He, Liang
    Nan, Xueyan
    Wang, Tong
    Bai, Pengli
    [J]. MICRO & NANO LETTERS, 2020, 15 (05) : 291 - 295
  • [45] Label-Free Luminescent Mesoporous Silica Nanoparticles for Imaging and Drug Delivery
    Chen, Hongmin
    Zhen, Zipeng
    Tang, Wei
    Todd, Trever
    Chuang, Yen-Jun
    Wang, Lianchun
    Pan, Zhengwei
    Xie, Jin
    [J]. THERANOSTICS, 2013, 3 (09): : 650 - 657
  • [46] Mesoporous silica nanoparticles: importance of surface modifications and its role in drug delivery
    Natarajan, Siva Kumar
    Selvaraj, Stalin
    [J]. RSC ADVANCES, 2014, 4 (28): : 14328 - 14334
  • [47] Functionalized Mesoporous Silica Nanoparticles as Delivery Systems for Doxorubicin: Drug Loading and Release
    Day, Candace M.
    Sweetman, Martin J.
    Song, Yunmei
    Plush, Sally E.
    Garg, Sanjay
    [J]. APPLIED SCIENCES-BASEL, 2021, 11 (13):
  • [48] Advances in mesoporous silica nanoparticles for targeted stimuli-responsive drug delivery
    Baeza, Alejandro
    Colilla, Montserrat
    Vallet-Regi, Maria
    [J]. EXPERT OPINION ON DRUG DELIVERY, 2015, 12 (02) : 319 - 337
  • [49] Advances in Functionalized Mesoporous Silica Nanoparticles for Tumor Targeted Drug Delivery and Theranostics
    Zhang, Wenjia
    Liu, Mengrui
    Liu, Anchang
    Zhai, Guangxi
    [J]. CURRENT PHARMACEUTICAL DESIGN, 2017, 23 (23) : 3367 - 3382
  • [50] Drug delivery systems based on mesoporous silica nanoparticles for the management of hepatic diseases
    Liu, Boyan
    Liu, Wenshi
    Xu, Miao
    Zhao, Tongyi
    Zhou, Bingxin
    Zhou, Ruilin
    Zhu, Ze
    Chen, Xuchun
    Bao, Zhiye
    Wang, Keke
    Li, Heran
    [J]. ACTA PHARMACEUTICA SINICA B, 2025, 15 (02) : 809 - 833